Significant Clinical Benefit of Pemetrexed-based Chemotherapy for Advanced Diffuse Malignant Peritoneal Mesothelioma: A Case Presentation

Diffuse malignant peritoneal mesothelioma (DMPM) is generally an understudied disease, largely because most molecular and clinical studies of mesothelioma have been conducted in patients with the more common malignant pleural mesothelioma. We present the case of a 45-year-old male that initially pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Peitl, Milena, Seiwerth, Sven, Bašić-Koretić, Martina, Šantek, Fedor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Practitioner Section
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398113/
https://www.ncbi.nlm.nih.gov/pubmed/28469343
http://dx.doi.org/10.4103/0971-5851.203495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5398113/
https://www.ncbi.nlm.nih.gov/pubmed/28469343
http://dx.doi.org/10.4103/0971-5851.203495

Ejemplares similares